Fibromyalgia

>

Latest News

New Fibromyalgia Treatment: FDA Approves Once-Daily Nonopioid Analgesic TNX-102 SL
New Fibromyalgia Treatment: FDA Approves Once-Daily Nonopioid Analgesic TNX-102 SL

August 15th 2025

FDA approves Tonmya, a groundbreaking treatment for fibromyalgia, offering hope to millions suffering from chronic pain and sleep issues.

FDA Assigns PDUFA Date for TNX-102 SL, a Nonopioid Analgesic for Fibromyalgia
FDA Assigns PDUFA Date for TNX-102 SL, a Nonopioid Analgesic for Fibromyalgia

January 2nd 2025

FDA accepts NDA for TNX-102 SL, Tonix Pharmaceuticals nonopioid analgesic for fibromyalgia  / image credit FDA HQ ©Tada Images/stock.adobe.com
FDA Accepts NDA for TNX-102 SL, Tonix Nonopioid Analgesic for Fibromyalgia

December 17th 2024

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: Long-term Opioid Use Affects 1 in 5 with Musculoskeletal Pain

May 18th 2023

First Opioid Rx Leads to Long-term Use in 1 of 5 with Rheumatic or Musculoskeletal Disorders  ©Deni/stock.adobe.com
First Opioid Rx Leads to Long-term Use in 1 of 5 with Rheumatic or Musculoskeletal Disorders

May 17th 2023

More News

© 2025 MJH Life Sciences

All rights reserved.